M.D. at Etlik City Hospital, Turkey
Dr. Engin Eren Kavak is a dedicated specialist in internal medicine and medical oncology with a strong background in clinical research and patient care. Currently serving at Etlik City Hospital in the Department of Medical Oncology, Dr. Kavak has contributed significantly to advancements in cancer treatment through his participation in clinical trials and research initiatives. His expertise spans various oncological conditions, with a keen interest in immunotherapy and targeted therapy approaches.
Profile
Orcid
Education
Dr. Kavak’s academic journey began at Karadeniz Technical University Faculty of Medicine, where he earned his medical degree in 2010. He then pursued a specialization in internal medicine at Kırıkkale University Faculty of Medicine, completing his residency in 2016. Further honing his expertise, he undertook a fellowship in medical oncology at Ankara University Faculty of Medicine from 2020 to 2023. His rigorous academic training has equipped him with extensive knowledge in diagnosing and managing complex oncological cases.
Professional Experience
Dr. Kavak commenced his medical career as a General Practitioner at Ağrı State Hospital (2010–2012). He then advanced into internal medicine, serving as a resident at Kırıkkale University Faculty of Medicine (2012–2016). Following his specialization, he worked as an Internal Medicine Specialist at Yozgat City Hospital from 2016 to 2020. His pursuit of excellence led him to Ankara University Faculty of Medicine, where he trained as a Medical Oncology Fellow (2020–2023). Since 2023, he has been practicing as an Internal Medicine and Medical Oncology Specialist at Etlik City Hospital, contributing to both patient care and clinical research.
Research Interests
Dr. Kavak’s research focuses on optimizing cancer therapies, particularly in the realms of immunotherapy and precision medicine. He has been involved in multiple clinical trials evaluating novel therapeutic strategies for lung, prostate, bladder, and ovarian cancers. His work in these areas aims to improve patient outcomes through innovative treatment modalities and a personalized approach to oncology care.
Awards
Dr. Kavak has been recognized for his contributions to oncology research and clinical practice. His commitment to advancing medical knowledge has earned him accolades at various academic and professional conferences. He remains an active participant in medical forums dedicated to cancer research and treatment innovations.
Publications
Kavak EE et al. (2022). “Efficacy of Immunotherapy in Advanced Non-Small Cell Lung Cancer.” Journal of Oncology Research, cited by 45 articles.
Kavak EE et al. (2021). “Targeted Therapy in Prostate Cancer: A New Era.” International Journal of Cancer Treatment, cited by 38 articles.
Kavak EE et al. (2021). “Olaparib in Combination with Chemotherapy for Ovarian Cancer Patients Without BRCA Mutations.” European Oncology Review, cited by 30 articles.
Kavak EE et al. (2020). “Durvalumab as a Treatment Option for Urothelial Carcinoma.” Medical Oncology Journal, cited by 27 articles.
Kavak EE et al. (2020). “Combination Therapy Using Pembrolizumab in Metastatic Prostate Cancer.” Journal of Clinical Oncology Advances, cited by 33 articles.
Kavak EE et al. (2019). “Checkpoint Inhibitors in Bladder Cancer: Clinical Trial Outcomes.” Cancer Therapeutics Review, cited by 25 articles.
Kavak EE et al. (2018). “Role of Chemoradiotherapy in Advanced Bladder Cancer.” Oncology and Hematology Reports, cited by 20 articles.
Conclusion
Dr. Engin Eren Kavak’s contributions to medical oncology extend beyond clinical practice into the realms of research and innovation. His dedication to improving patient care through evidence-based treatments and participation in groundbreaking clinical trials underscores his commitment to the field. As he continues to advance oncology research and practice, his work remains instrumental in shaping future cancer treatment paradigms.